Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ((cell-free) AND dna) AND biomarkers:

Search results

Items: 1 to 20 of 1422

1.

Voltammetric immunosensor for E-cadherin promoter DNA methylation using a Fe3O4-citric acid nanocomposite and a screen-printed carbon electrode modified with poly(vinyl alcohol) and reduced graphene oxide.

Khodaei R, Ahmady A, Khoshfetrat SM, Kashanian S, Tavangar SM, Omidfar K.

Mikrochim Acta. 2019 Feb 11;186(3):170. doi: 10.1007/s00604-019-3234-y.

PMID:
30741341
2.

Early detection of the PAX3-FOXO1 fusion gene in circulating tumor-derived DNA in a case of alveolar rhabdomyosarcoma.

Eguchi-Ishimae M, Tezuka M, Kokeguchi T, Nagai K, Moritani K, Yonezawa S, Tauchi H, Tokuda K, Ishida Y, Ishii E, Eguchi M.

Genes Chromosomes Cancer. 2019 Feb 10. doi: 10.1002/gcc.22734. [Epub ahead of print]

PMID:
30739374
3.

The Developing Story of Predictive Biomarkers in Colorectal Cancer.

Boussios S, Ozturk MA, Moschetta M, Karathanasi A, Zakynthinakis-Kyriakou N, Katsanos KH, Christodoulou DK, Pavlidis N.

J Pers Med. 2019 Feb 7;9(1). pii: E12. doi: 10.3390/jpm9010012. Review.

4.

Evaluation of Storage Tubes for Combined Analysis of Circulating Nucleic Acids in Liquid Biopsies.

Ward Gahlawat A, Lenhardt J, Witte T, Keitel D, Kaufhold A, Maass KK, Pajtler KW, Sohn C, Schott S.

Int J Mol Sci. 2019 Feb 6;20(3). pii: E704. doi: 10.3390/ijms20030704.

5.

Enhanced Neutrophil Extracellular Trap Formation in Acute Pancreatitis Contributes to Disease Severity and Is Reduced by Chloroquine.

Murthy P, Singhi AD, Ross MA, Loughran P, Paragomi P, Papachristou GI, Whitcomb DC, Zureikat AH, Lotze MT, Zeh Iii HJ, Boone BA.

Front Immunol. 2019 Jan 24;10:28. doi: 10.3389/fimmu.2019.00028. eCollection 2019.

6.

Serum cell-free DNA levels are useful marker for extramammary Paget's disease.

Mijiddorj T, Kajihara I, Tasaki Y, Otsuka-Maeda S, Sakamoto R, Sawamura S, Kanazawa-Yamada S, Egashira S, Inoue K, Makino K, Miyashita A, Aoi J, Igata T, Makino T, Masuguchi S, Fukushima S, Jinnin M, Morinaga J, Ikeda T, Ihn H.

Br J Dermatol. 2019 Feb 1. doi: 10.1111/bjd.17709. [Epub ahead of print]

PMID:
30706452
7.

Cell-free DNA Analysis in Cancer.

Fiala C, Diamandis EP.

N Engl J Med. 2019 Jan 31;380(5):501. doi: 10.1056/NEJMc1816154. No abstract available.

PMID:
30702289
8.

Cell-free DNA Analysis in Cancer.

Corcoran RB, Chabner BA.

N Engl J Med. 2019 Jan 31;380(5):501-502. doi: 10.1056/NEJMc1816154. No abstract available.

PMID:
30699310
9.

Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.

Petit J, Carroll G, Gould T, Pockney P, Dun M, Scott RJ.

J Surg Res. 2019 Apr;236:184-197. doi: 10.1016/j.jss.2018.11.029. Epub 2018 Dec 21. Review.

PMID:
30694754
10.

Detection of BRAFV600E Mutation in Melanoma Patients by Digital PCR of Circulating DNA.

Burjanivova T, Malicherova B, Grendar M, Minarikova E, Dusenka R, Vanova B, Bobrovska M, Pecova T, Homola I, Lasabova Z, Plank L.

Genet Test Mol Biomarkers. 2019 Jan 24. doi: 10.1089/gtmb.2018.0193. [Epub ahead of print]

PMID:
30676087
11.

A label-free, ultra-highly sensitive and multiplexed SERS nanoplasmonic biosensor for miRNA detection using a head-flocked gold nanopillar.

Kim WH, Lee JU, Song S, Kim S, Choi YJ, Sim SJ.

Analyst. 2019 Jan 23. doi: 10.1039/c8an01745j. [Epub ahead of print]

PMID:
30672519
12.

Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies.

Eikmans M, Gielis EM, Ledeganck KJ, Yang J, Abramowicz D, Claas FFJ.

Front Med (Lausanne). 2019 Jan 8;5:358. doi: 10.3389/fmed.2018.00358. eCollection 2018. Review.

13.

Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?

Moutinho-Ribeiro P, Macedo G, Melo SA.

Front Endocrinol (Lausanne). 2019 Jan 8;9:779. doi: 10.3389/fendo.2018.00779. eCollection 2018. Review.

14.

Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.

Gai W, Sun K.

Genes (Basel). 2019 Jan 9;10(1). pii: E32. doi: 10.3390/genes10010032. Review.

15.

Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers.

Herrera-Martínez AD, Hofland LJ, Gálvez Moreno MA, Castaño JP, de Herder WW, Feelders RA.

Endocr Relat Cancer. 2019 Mar 1;26(3):R157-R179. doi: 10.1530/ERC-18-0354. Review.

PMID:
30615596
16.

Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria.

Amado V, Rodríguez-Perálvarez M, Ferrín G, De la Mata M.

J Hepatocell Carcinoma. 2018 Dec 21;6:1-10. doi: 10.2147/JHC.S174549. eCollection 2019. Review.

17.

[Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].

Qiu YW, Shen XJ, Jin CJ, Cao XJ, Ju SQ.

Zhonghua Zhong Liu Za Zhi. 2018 Dec 23;40(12):905-910. doi: 10.3760/cma.j.issn.0253-3766.2018.12.006. Chinese.

PMID:
30605980
18.

Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility.

Pantel K, Hille C, Scher HI.

Clin Chem. 2019 Jan;65(1):87-99. doi: 10.1373/clinchem.2018.287102. Review.

PMID:
30602476
19.

TAC-seq: targeted DNA and RNA sequencing for precise biomarker molecule counting.

Teder H, Koel M, Paluoja P, Jatsenko T, Rekker K, Laisk-Podar T, Kukuškina V, Velthut-Meikas A, Fjodorova O, Peters M, Kere J, Salumets A, Palta P, Krjutškov K.

NPJ Genom Med. 2018 Dec 18;3:34. doi: 10.1038/s41525-018-0072-5. eCollection 2018.

20.

Urinary Cell-Free DNA: Potential and Applications.

Salvi S, Casadio V.

Methods Mol Biol. 2019;1909:201-209. doi: 10.1007/978-1-4939-8973-7_15.

PMID:
30580433

Supplemental Content

Loading ...
Support Center